June 24, 2008

Takeda Pharmaceutical Company Limited

Notice of Execution of Acquisition of the Company’s Own Shares

Osaka, Japan, June 24, 2008 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on May 9, 2008.

1. Class of shares acquired:	Shares of common stock
2. Period of acquisition:	From May 12, 2008 to June 20, 2008
3. Total number of shares acquired:	16,994,200 shares
4. Total value of acquisition:	Yen 99,999,796,000
5. Method of acquisition:	Purchased on the Tokyo Stock Exchange

(Reference)

Resolution of the Board of Directors on May 9, 2008

1.	Class of shares to be acquired:	Shares of common stock
2.	Number of shares to be acquired:	Up to 18 million shares
		(equivalent to 2.02% of the total issued shares)
3.	Total amount of shares to be acquired:	Up to 100 billion Yen
4.	Schedule of acquisition:	From May 12, 2008 to June 23, 2008

Treasury shares held by Takeda as of June 23, 2008

1. Aggregate number of issued shares:	814,946,978 shares
	(excluding treasury shares)
2. Number of treasury shares:	17,195,417 shares

# # #